0

Coronary Risk Factors Collection
 101-120 of 215 Articles
ACP Journal Club |  21 June 2011
Review: Antihypertensive treatment prevents cardiovascular events and mortality in cardiovascular disease without hypertension
Jay N. Cohn, MD
Ann Intern Med. 2011;154(12):JC6-6. doi:10.7326/0003-4819-154-12-201106210-02006
ACP Journal Club |  21 June 2011
PPI use in the first trimester was not associated with increased risk for birth defects; PPI use 1 to 4 weeks before conception was
Rory Windrim, MD
Ann Intern Med. 2011;154(12):JC6-11. doi:10.7326/0003-4819-154-12-201106210-02011
ACP Journal Club |  17 May 2011
Intensive glucose control increased mortality and did not prevent CV events compared with standard glucose control in type 2 diabetes
Rozalina Grubina, MD; Steven A. Smith, MD
Ann Intern Med. 2011;154(10):JC5-2. doi:10.7326/0003-4819-154-10-201105170-02002
ACP Journal Club |  17 May 2011
Meta-analysis: More intensive statin therapy prevents major vascular events
Donald A. Smith, MD, MPH, FACP, FNLA, FACE
Ann Intern Med. 2011;154(10):JC5-3. doi:10.7326/0003-4819-154-10-201105170-02003
ACP Journal Club |  17 May 2011
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions
Reem Mustafa, MD, MPH; Amit X. Garg, MD, PhD
Ann Intern Med. 2011;154(10):JC5-5. doi:10.7326/0003-4819-154-10-201105170-02005
ACP Journal Club |  17 May 2011
Review: Low-dose hydrochlorothiazide is not as effective as other antihypertensive drugs for reducing ambulatory BP in hypertension?
Eugene Yang, MD, FACC
Ann Intern Med. 2011;154(10):JC5-8. doi:10.7326/0003-4819-154-10-201105170-02008
ACP Journal Club |  17 May 2011
Prescription omega-3 fatty acids did not prevent recurrent, symptomatic, paroxysmal or persistent atrial fibrillation
Brian Olshansky, MD
Ann Intern Med. 2011;154(10):JC5-9. doi:10.7326/0003-4819-154-10-201105170-02009
ACP Journal Club |  19 April 2011
Review: Varenicline is better than placebo or bupropion, but not clearly different from the nicotine patch, for smoking abstinence
James Brophy, MD, PhD
Ann Intern Med. 2011;154(8):JC4-4. doi:10.7326/0003-4819-154-8-201104190-02004
ACP Journal Club |  19 April 2011
HbA1c levels had low sensitivity but high specificity for screening for diabetes
Lorraine Lipscombe, MD, MSc, FRCPC
Ann Intern Med. 2011;154(8):JC4-9. doi:10.7326/0003-4819-154-8-201104190-02009
ACP Journal Club |  15 March 2011
Elevated HbA1c levels (5.7% to 6.4%) had low accuracy for diagnosing prediabetes
Yogish C. Kudva, MD; Ananda Basu, MD
Ann Intern Med. 2011;154(6):JC3-11. doi:10.7326/0003-4819-154-6-201103150-02011
ACP Journal Club |  15 February 2011
Pharmacist–physician hypertension comanagement reduced 24-hour ambulatory blood pressure
Brett D. Montgomery, MBBS, DCH, FRACGP
Ann Intern Med. 2011;154(4):JC2-9. doi:10.7326/0003-4819-154-4-201102150-02009
ACP Journal Club |  15 February 2011
Severe hypoglycemia was associated with increased risk for adverse clinical outcomes in type 2 diabetes
Rozalina Grubina, MD; Steven A. Smith, MD
Ann Intern Med. 2011;154(4):JC2-13. doi:10.7326/0003-4819-154-4-201102150-02013
ACP Journal Club |  21 December 2010
Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MI
Herbert D. Aronow, MD, MPH
Ann Intern Med. 2010;153(12):JC6-13. doi:10.7326/0003-4819-153-12-201012210-02013
ACP Journal Club |  16 November 2010
Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD
Chi-yuan Hsu, MD, MSc
Ann Intern Med. 2010;153(10):JC5-3. doi:10.7326/0003-4819-153-10-201011160-02003
ACP Journal Club |  16 November 2010
Intensive glucose control did not reduce a composite of microvascular events more than standard control in type 2 diabetes
David C. Aron, MD, MS; Leonard M. Pogach, MD, MBA
Ann Intern Med. 2010;153(10):JC5-9. doi:10.7326/0003-4819-153-10-201011160-02009
ACP Journal Club |  16 November 2010
Intensifying glucose control and adding fenofibrate to simvastatin each reduced progression of retinopathy in type 2 diabetes
David L. Bronson, MD, FACP
Ann Intern Med. 2010;153(10):JC5-10. doi:10.7326/0003-4819-153-10-201011160-02010
ACP Journal Club |  19 October 2010
Benazepril plus amlodipine reduced CV events more than benazepril plus hydrochlorothiazide in hypertension with or without diabetes
Srinivas Merugu, MD
Ann Intern Med. 2010;153(8):JC4-2. doi:10.7326/0003-4819-153-8-201010190-02002
ACP Journal Club |  19 October 2010
Prior intensive insulin treatment reduced long-term risk for peripheral neuropathy in type 1 diabetes
Mario Di Napoli, MD
Ann Intern Med. 2010;153(8):JC4-3. doi:10.7326/0003-4819-153-8-201010190-02003
ACP Journal Club |  19 October 2010
Aspirin alone or combined with nadroparin did not increase live birth rates in women with unexplained recurrent miscarriage
Christopher J. Robinson, MD, MSCR
Ann Intern Med. 2010;153(8):JC4-7. doi:10.7326/0003-4819-153-8-201010190-02007
ACP Journal Club |  19 October 2010
Review: Vibration testing and monofilament testing are most accurate for diagnosing large-fiber peripheral neuropathy in diabetes
David R. Gutknecht, MD
Ann Intern Med. 2010;153(8):JC4-10. doi:10.7326/0003-4819-153-8-201010190-02010
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)